RxDoctor Payments Data

Gina Leman

Family · Brownsburg, INNPI 1942569371

Payments from drug & device makers

$4,024in general payments, 2019–2025

Across 225 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$716
  • AbbVie$413
  • Lilly USA, LLC$410
  • GSK$379
  • AstraZeneca$377
  • Pfizer$264
  • plus $1K from 30 others

What the payments were for

  • Food & beverage$4,024100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,024 in reported general payments places this provider in the 90th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$24,248
Medicare patients
113
Services billed
393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide20$27,797
ProliaDenosumab14$24,436
JanuviaSitagliptin Phosphate13$15,178
VascepaIcosapent Ethyl11$3,799
Candesartan-HydrochlorothiazidCandesartan/Hydrochlorothiazid11$1,638
Desvenlafaxine Succinate ErDesvenlafaxine Succinate13$1,213
Omeprazole35$877
Atorvastatin Calcium98$804
Ezetimibe11$784
Bupropion XlBupropion Hcl25$759
Potassium Chloride45$740
Pregabalin26$730
Valsartan21$691
Rosuvastatin Calcium73$645
Levothyroxine Sodium67$563

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus$716$27,79720 claims
AmgenProlia$125$24,43614 claims
MerckJanuvia$77$15,17813 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$18$56367 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,392 family providers in Indiana.

Other family in Brownsburg

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →